1. Home
  2. CAAS vs ENTA Comparison

CAAS vs ENTA Comparison

Compare CAAS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.28

Market Cap

123.7M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.73

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
ENTA
Founded
N/A
1995
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.7M
407.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CAAS
ENTA
Price
$4.28
$14.73
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
30.8K
298.8K
Earning Date
11-12-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
5.68
N/A
EPS
1.11
N/A
Revenue
$725,260,000.00
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$0.19
P/E Ratio
$3.86
N/A
Revenue Growth
16.72
N/A
52 Week Low
$3.50
$4.09
52 Week High
$5.37
$15.34

Technical Indicators

Market Signals
Indicator
CAAS
ENTA
Relative Strength Index (RSI) 56.17 67.09
Support Level $4.06 $13.75
Resistance Level $4.30 $14.79
Average True Range (ATR) 0.13 0.74
MACD 0.03 -0.01
Stochastic Oscillator 62.22 90.89

Price Performance

Historical Comparison
CAAS
ENTA

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: